Rabepes MUPS 20 mg (MUPS Tablet)
Unit Price: ৳ 10.00 (5 x 10: ৳ 500.00)
Strip Price: ৳ 100.00
Medicine Details
Category | Details |
---|---|
Generic | Rabeprazole sodium |
Company | Beacon pharmaceuticals plc |
Also available as |
Title
- Rabepes MUPS Gastro-resistant Tablet
Categories
- Medicine
- Gastrointestinal Health
- Proton Pump Inhibitor
Description
- Gastro-resistant tablets for the treatment of various gastrointestinal conditions
Active Ingredients
- Rabeprazole Sodium
Dosage Form
- Tablet
Dosage Strengths
- 5mg
- 10mg
- 20mg
- 60mg
- 120mg
Dosage Instructions
- Once daily administration in the morning for most conditions
Indications
- Active Duodenal Ulcer
- Active Benign Gastric Ulcer
- GERD
- Zollinger-Ellison Syndrome
Treatment Duration
- 4-8 weeks for most conditions
Maintenance Dose
- 10mg or 20mg daily for long-term management of GERD
Pediatric Dosage
- 5mg for <15kg weight
- 10mg for ≥15kg weight
H. pylori Eradication Regimen
- Rabeprazole 20mg twice daily, clarithromycin 500mg twice daily, amoxicillin 1g twice daily for 7 days
Administration
- Morning intake before eating
Storage Conditions
- Below 30°C, away from light and moisture
Contraindications
- Hypersensitivity to the active substance or excipients
- Pregnancy
- Breastfeeding
Side Effects
- Headache
- Diarrhea
- Abdominal pain
- Vomiting
- Constipation
Pregnancy Category
- Category C
Warnings
- Symptomatic response does not exclude malignancy
- Risk of fractures with long-term use
- Cross-hypersensitivity reactions
- Liver enzyme abnormalities
Drug Interaction
- Potential interactions with ketoconazole, itraconazole
- Avoid co-administration with atazanavir
Overdose Effects
- Limited effects due to reversible adverse events
- No specific antidote known
Chemical Structure
- Molecular Formula: C18H21N3O3S
- Chemical Structure Image Provided
Pediatric Use
- Not recommended for use in children due to lack of data on safety and efficacy
Avoidable Interactions
- Liquid antacids
- Atazanavir
Hypomagnesaemia Risk
- Severe hypomagnesaemia reported after prolonged PPI use
Bone Health Concerns
- Long-term use may lead to osteoporosis
Vitamin B12 Absorption
- Potential reduction due to acid-blocking effects
Precautions
- Regular surveillance for long-term users
- Measure magnesium levels regularly
Special Populations
- Considerations for renal and hepatic impairment
Therapeutic Class
- Proton Pump Inhibitor
Usability Tips
- Take with food
- Swallow whole, do not chew or crush
Common Questions
- Uses
- Side effects
- Dosage instructions
- Safety during pregnancy and breastfeeding
Precautions for Laboratory Tests
- Effects on Chromogranin A levels
- Stop treatment before CgA measurements
Observation Period for Patient Response
- Investigate further if symptom control not achieved after 4 weeks
Related Brands
- Tagus 20 mg (Tablet (Enteric Coated)) - healthcare-pharmaceuticals-ltd
- Tagus 10 mg (Tablet (Enteric Coated)) - healthcare-pharmaceuticals-ltd
- Xorel MUPS 20 mg (MUPS Tablet) - ibn-sina-pharmaceuticals-ltd
- Rabefour 20 mg (Capsule (Enteric Coated)) - albion-laboratories-limited
- Rabetol 20 mg (Tablet (Enteric Coated)) - biogen-pharmaceuticals-ltd